User contributions for Badgettrg
Jump to navigation
Jump to search
11 October 2023
- 21:1421:14, 11 October 2023 diff hist +720 Positive deviance →Interventions and assessments using positive deviants
10 October 2023
- 12:3512:35, 10 October 2023 diff hist +559 Hospital readmissions →Adults
- 12:1712:17, 10 October 2023 diff hist +1,211 Hospital readmissions →Adults
1 October 2023
- 16:0816:08, 1 October 2023 diff hist +511 Statistics →Misuse
27 September 2023
20 September 2023
- 22:3722:37, 20 September 2023 diff hist +14,170 N Death new page with content from CZ current
19 September 2023
- 00:0100:01, 19 September 2023 diff hist +7 Attention-deficit hyperactivity disorder monitoring response to therapy →Monitoring response to treatment
16 September 2023
- 19:4619:46, 16 September 2023 diff hist +27 Cervical cancer screening →Screening Guidelines current
- 19:4519:45, 16 September 2023 diff hist +1,692 Cervical cancer screening No edit summary
12 September 2023
- 20:1720:17, 12 September 2023 diff hist +689 Non-alcoholic fatty liver disease natural history, complications and prognosis →Prognosis
10 September 2023
- 07:5707:57, 10 September 2023 diff hist +673 Gout medical therapy →Prophylaxis to prevent acute gout flares during initiation of uric acid lowering therapy current
- 02:3602:36, 10 September 2023 diff hist +244 Non-alcoholic fatty liver disease overview new AASLD nomenclature current Tag: Visual edit: Switched
- 02:3402:34, 10 September 2023 diff hist +66 Non-alcoholic fatty liver disease added MASLD to synonyms
- 02:3302:33, 10 September 2023 diff hist +47 N Masld #REDIRECT current Tag: New redirect
- 02:3302:33, 10 September 2023 diff hist +47 N Metabolic dysfunction-associated steatotic liver disease #REDIRECT current Tag: New redirect
6 September 2023
- 18:5918:59, 6 September 2023 diff hist +562 Anxiety medical therapy →Medical Therapy current
- 17:4917:49, 6 September 2023 diff hist +1,507 Anxiety medical therapy →Pharmacotherapy
- 16:5916:59, 6 September 2023 diff hist +504 Anxiety medical therapy →Pharmacotherapy
2 September 2023
- 14:2314:23, 2 September 2023 diff hist +560 Industrial and organizational psychology →Hiring practices
- 14:2214:22, 2 September 2023 diff hist +563 Leadership →Self-selection reasons
- 14:0114:01, 2 September 2023 diff hist +684 Leadership →Selection and development of leaders
- 14:0114:01, 2 September 2023 diff hist +1,503 Industrial and organizational psychology →Hiring practices
1 September 2023
- 20:0820:08, 1 September 2023 diff hist +590 Non-alcoholic fatty liver disease natural history, complications and prognosis →Prognosis
31 August 2023
- 06:0506:05, 31 August 2023 diff hist +718 Non-alcoholic fatty liver disease natural history, complications and prognosis →NAFLD with normal liver enzymes
29 August 2023
- 21:5421:54, 29 August 2023 diff hist +732 Non-alcoholic fatty liver disease natural history, complications and prognosis →Natural History
- 21:4321:43, 29 August 2023 diff hist +122 Non-alcoholic fatty liver disease natural history, complications and prognosis →NAFLD with normal liver enzymes =
- 21:3521:35, 29 August 2023 diff hist +1,285 Non-alcoholic fatty liver disease natural history, complications and prognosis →Natural History
25 August 2023
- 01:4901:49, 25 August 2023 diff hist +1,210 Non-alcoholic fatty liver disease screening →Screening current
23 August 2023
- 03:2803:28, 23 August 2023 diff hist +376 Immunotherapy No edit summary current
- 02:0802:08, 23 August 2023 diff hist 0 m Non-alcoholic fatty liver disease Noninvasive scores No edit summary
- 02:0602:06, 23 August 2023 diff hist +775 Non-alcoholic fatty liver disease Noninvasive scores No edit summary
- 01:5401:54, 23 August 2023 diff hist +596 Non-alcoholic fatty liver disease Noninvasive scores Fibrotic NASH Index (FNI)
22 August 2023
- 15:4715:47, 22 August 2023 diff hist +66 Non-alcoholic fatty liver disease natural history, complications and prognosis →Natural History, Complications and Prognosis
- 15:4515:45, 22 August 2023 diff hist +142 Non-alcoholic fatty liver disease Noninvasive scores No edit summary
- 15:4315:43, 22 August 2023 diff hist +70 Non-alcoholic fatty liver disease Noninvasive scores No edit summary
- 15:4115:41, 22 August 2023 diff hist +1,532 Non-alcoholic fatty liver disease Noninvasive scores No edit summary
20 August 2023
- 12:3912:39, 20 August 2023 diff hist +379 Leadership →Self-selection reasons
- 04:0004:00, 20 August 2023 diff hist +1,310 Leadership →Selection and development of leaders
18 August 2023
- 23:3823:38, 18 August 2023 diff hist +738 Chronic hypertension medical therapy →Selecting medication based on patient demographics
16 August 2023
- 14:5514:55, 16 August 2023 diff hist +1,714 Non-alcoholic fatty liver disease medical therapy →Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA)
- 13:5213:52, 16 August 2023 diff hist +274 Non-alcoholic fatty liver disease medical therapy →Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA)
- 03:4403:44, 16 August 2023 diff hist +1,258 Non-alcoholic fatty liver disease medical therapy →Weight management
- 01:0901:09, 16 August 2023 diff hist +64 Non-alcoholic fatty liver disease natural history, complications and prognosis →Prognosis estimated based on treatment
13 August 2023
- 02:0002:00, 13 August 2023 diff hist +3 Non-alcoholic fatty liver disease natural history, complications and prognosis →Prognosis
12 August 2023
- 19:3019:30, 12 August 2023 diff hist +2,199 Non-alcoholic fatty liver disease natural history, complications and prognosis →Prognosis
- 19:2619:26, 12 August 2023 diff hist +806 Non-alcoholic fatty liver disease medical therapy →Medical Therapy